SCHEMBL5679697

SCHEMBL5679697

CC=C1CCCCC1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18898801 0.82
SCHEMBL16373416 0.78
SCHEMBL13877116 0.76
SCHEMBL10667910 0.76 TSHR (0.44)
SCHEMBL6600699 0.76 NOS1 (0.33)
SCHEMBL4736148 0.73
SCHEMBL4736150 0.73
SCHEMBL1171183 0.73 MYC (0.30)
SCHEMBL11450880 0.73 NOS1 (0.33)
SCHEMBL974938 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276653-A1 Process for producing quinoline compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2006-12-07 US disclosed
EP-1614682-A1 PROCESS FOR PRODUCING QUINOLINE COMPOUND Nissan Chemical Industries, Ltd. (JP) 2006-01-11 EP disclosed
US-5132312-A 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors as anticholesterol agents RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1992-07-21 US disclosed
WO-1991013616-A1 NOVEL HMG-CoA REDUCTASE INHIBITORS RORER INTERNATIONAL (OVERSEAS) INC. (US) 1991-09-19 WO disclosed
EP-0403487-A4 NOVEL HMG-COA REDUCTASE INHIBITORS 1991-06-05 EP disclosed
WO-1991004736-A1 SUBSTITUTED CYCLOHEXENE DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS RORER INTERNATIONAL (OVERSEAS) INC. (US) 1991-04-18 WO disclosed
US-5001144-A Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-03-19 US disclosed
US-4996234-A Anticholesterol agents RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-02-26 US disclosed
US-4994494-A HMG-COA reductase inhibitors RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-02-19 US disclosed
EP-0403487-A1 NOVEL HMG-CoA REDUCTASE INHIBITORS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1990-12-27 EP disclosed
US-4322563-A Substituted biphenyl-2-carboxaldehydes MERCK & CO., INC. (US) 1982-03-30 US disclosed
US-4308378-A Cis/trans isomerization of 6-(substituted-aryl-ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones MERCK & CO., INC. (US) 1981-12-29 US disclosed
EP-0038061-A1 Substituted biphenyl-2-carboxaldehydes and a process for preparing them MERCK & CO. INC. (US) 1981-10-21 EP disclosed
EP-0024348-A1 Substituted 6-Phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-R trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them MERCK & CO. INC. (US) 1981-03-04 EP disclosed
US-4226892-A Flavoring with cycloaliphatic unsaturated ketones FIRMENICH SA (CH) 1980-10-07 US disclosed
US-4187863-A Cycloaliphatic unsaturated ketones as odor and taste modifying agents in tobacco products FIRMENICH SA (CH) 1980-02-12 US disclosed
US-4102888-A VASODILATORS, ANTITHROMBITIC MERCK & CO., INC. (US) 1978-07-25 US disclosed
US-4059587-A 8-AZA-9-OXO-11-THIA-PROSTANOIC ACID DERIVATIVES; VASODILATORS, ANTICLOTTING, REGULATORS OF IMMUNE RESPONSE MERCK & CO., INC. (US) 1977-11-22 US disclosed
US-3975310-A PERFUME FIRMENICH S.A. (CH) 1976-08-17 US disclosed
US-3931326-A FLAVOR, TASTE, ODOR, PERFUMES FIRMENICH SA (CH) 1976-01-06 US disclosed